TFM
SRNE

TFC Financial Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

TFC Financial Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-893
Closed -$791 – 704
2022
Q4 		$791 Hold
893
– – ﹤0.01% 484
2022
Q3 		$1K Hold
893
– – ﹤0.01% 518
2022
Q2 		$2K Hold
893
– – ﹤0.01% 432
2022
Q1 		$2K Hold
893
– – ﹤0.01% 448
2021
Q4 		$4K Hold
893
– – ﹤0.01% 417
2021
Q3 		$7K Buy
893
+2
+0.2% +$17 ﹤0.01% 366
2021
Q2 		$9K Hold
891
– – ﹤0.01% 332
2021
Q1 		$7K Hold
891
– – ﹤0.01% 335
2020
Q4 		$6K Hold
891
– – ﹤0.01% 355
2020
Q3 		$10K Buy
+891
New +$8.15K ﹤0.01% 300

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

TFC Financial Management's SRNE Position: Q1 2023 in Review

TFC Financial Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 893 shares — an estimated $791 sold.

TFC Financial Management first reported a position in SRNE in Q3 2020 and held it in 10 quarters. The position peaked at $10K in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • TFC Financial Management reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • TFC Financial Management sold 893 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $791.
  • TFC Financial Management first reported a position in Sorrento Therapeutics, Inc. in Q3 2020 and held it in 10 quarters.
  • TFC Financial Management's Sorrento Therapeutics, Inc. position peaked at $10K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on TFC Financial Management's 13F filing for Q1 2023, filed 8 May 2023.